{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T13:50:17Z","timestamp":1767275417212,"version":"3.44.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100011110","name":"UCB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011110","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Ther"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s40744-025-00791-5","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T10:21:44Z","timestamp":1756462904000},"page":"991-1006","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Patient Diagnostic Journey and Time to Diagnosis in Axial Spondyloarthritis: A Retrospective Cohort Study Using US Claims Data"],"prefix":"10.1007","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6253-1515","authenticated-orcid":false,"given":"Maureen","family":"Dubreuil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6520-5619","authenticated-orcid":false,"given":"Marina","family":"Magrey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3134-7478","authenticated-orcid":false,"given":"Kathrin","family":"Haeffs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evgueni","family":"Ivanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4109-4889","authenticated-orcid":false,"given":"Julie","family":"Gandrup Horan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"key":"791_CR1","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1136\/annrheumdis-2021-221035","volume":"80","author":"V Navarro-Comp\u00e1n","year":"2021","unstructured":"Navarro-Comp\u00e1n V, Sepriano A, El-Zorkany B, et al. Axial spondyloarthritis. Ann Rheum Dis. 2021;80:1511\u201321.","journal-title":"Ann Rheum Dis"},{"key":"791_CR2","doi-asserted-by":"publisher","first-page":"e547","DOI":"10.1097\/RHU.0000000000001575","volume":"27","author":"JA Walsh","year":"2021","unstructured":"Walsh JA, Magrey M. Clinical manifestations and diagnosis of axial spondyloarthritis. J Clin Rheumatol. 2021;27:e547\u201360.","journal-title":"J Clin Rheumatol"},{"key":"791_CR3","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1136\/ard.2009.108233","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, van der Heijde D, Landew\u00e9 R, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009;68:777\u201383.","journal-title":"Ann Rheum Dis"},{"key":"791_CR4","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1136\/ard.2008.101501","volume":"68","author":"J Sieper","year":"2009","unstructured":"Sieper J, van der Heijde D, Landew\u00e9 R, et al. New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS). Ann Rheum Dis. 2009;68:784\u20138.","journal-title":"Ann Rheum Dis"},{"key":"791_CR5","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/RHU.0000000000000589","volume":"23","author":"V Strand","year":"2017","unstructured":"Strand V, Singh JA. Patient burden of axial spondyloarthritis. J Clin Rheumatol. 2017;23:383\u201391.","journal-title":"J Clin Rheumatol"},{"key":"791_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2019-001108","volume":"5","author":"C L\u00f3pez-Medina","year":"2019","unstructured":"L\u00f3pez-Medina C, Ramiro S, van der Heijde D, et al. Characteristics and burden of disease in patients with radiographic and non-radiographic axial spondyloarthritis: a comparison by systematic literature review and meta-analysis. RMD Open. 2019;5: e001108.","journal-title":"RMD Open"},{"key":"791_CR7","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1007\/s10067-016-3231-z","volume":"35","author":"A Deodhar","year":"2016","unstructured":"Deodhar A, Mittal M, Reilly P, et al. Ankylosing spondylitis diagnosis in US patients with back pain: identifying providers involved and factors associated with rheumatology referral delay. Clin Rheumatol. 2016;35:1769\u201376.","journal-title":"Clin Rheumatol"},{"key":"791_CR8","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1007\/s10067-022-06100-7","volume":"41","author":"CA Hay","year":"2022","unstructured":"Hay CA, Packham J, Ryan S, et al. Diagnostic delay in axial spondyloarthritis: a systematic review. Clin Rheumatol. 2022;41:1939\u201350.","journal-title":"Clin Rheumatol"},{"key":"791_CR9","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1093\/rheumatology\/keaa807","volume":"60","author":"SS Zhao","year":"2021","unstructured":"Zhao SS, Pittam B, Harrison NL, et al. Diagnostic delay in axial spondyloarthritis: a systematic review and meta-analysis. Rheumatology (Oxford). 2021;60:1620\u20138.","journal-title":"Rheumatology (Oxford)"},{"key":"791_CR10","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/acr2.11543","volume":"5","author":"M Magrey","year":"2023","unstructured":"Magrey M, Walsh JA, Flierl S, et al. The international map of axial spondyloarthritis survey: a US patient perspective on diagnosis and burden of disease. ACR Open Rheumatol. 2023;5:264\u201376.","journal-title":"ACR Open Rheumatol"},{"key":"791_CR11","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1007\/s10067-023-06671-z","volume":"42","author":"S Kiwalkar","year":"2023","unstructured":"Kiwalkar S, Howard R, Choi D, et al. A mixed methods study to uncover impediments to accurate diagnosis of nonradiographic axial spondyloarthritis in the USA. Clin Rheumatol. 2023;42:2811\u201322.","journal-title":"Clin Rheumatol"},{"key":"791_CR12","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s40744-019-0153-7","volume":"6","author":"A Ogdie","year":"2019","unstructured":"Ogdie A, Benjamin Nowell W, Reynolds R, et al. Real-world patient experience on the path to diagnosis of ankylosing spondylitis. Rheumatol Ther. 2019;6:255\u201367.","journal-title":"Rheumatol Ther"},{"key":"791_CR13","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1002\/art.38070","volume":"65","author":"N Haroon","year":"2013","unstructured":"Haroon N, Inman RD, Learch TJ, et al. The impact of tumor necrosis factor \u03b1 inhibitors on radiographic progression in ankylosing spondylitis. Arthritis Rheum. 2013;65:2645\u201354.","journal-title":"Arthritis Rheum"},{"key":"791_CR14","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/art.41206","volume":"72","author":"P Karmacharya","year":"2020","unstructured":"Karmacharya P, Duarte-Garcia A, Dubreuil M, et al. Effect of therapy on radiographic progression in axial spondyloarthritis: a systematic review and meta-analysis. Arthritis Rheumatol. 2020;72:733\u201349.","journal-title":"Arthritis Rheumatol"},{"key":"791_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s40744-023-00627-0","volume":"11","author":"D Mauro","year":"2024","unstructured":"Mauro D, Forte G, Poddubnyy D, et al. The role of early treatment in the management of axial spondyloarthritis: challenges and opportunities. Rheumatol Ther. 2024;11:19\u201334.","journal-title":"Rheumatol Ther"},{"key":"791_CR16","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12875-021-01599-2","volume":"22","author":"KL Lapane","year":"2021","unstructured":"Lapane KL, Dub\u00e9 C, Ferrucci K, et al. Patient perspectives on health care provider practices leading to an axial spondyloarthritis diagnosis: an exploratory qualitative research study. BMC Fam Pract. 2021;22:251.","journal-title":"BMC Fam Pract"},{"key":"791_CR17","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/acr2.11179","volume":"2","author":"M Magrey","year":"2020","unstructured":"Magrey M, Yi E, Wolin D, et al. Understanding barriers in the pathway to diagnosis of ankylosing spondylitis: results from a US survey of 1690 physicians from 10 specialties. ACR Open Rheumatol. 2020;2:616\u201326.","journal-title":"ACR Open Rheumatol"},{"key":"791_CR18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11926-019-0844-7","volume":"21","author":"D Poddubnyy","year":"2019","unstructured":"Poddubnyy D, Sieper J. Current unmet needs in spondyloarthritis. Curr Rheumatol Rep. 2019;21:43.","journal-title":"Curr Rheumatol Rep"},{"key":"791_CR19","unstructured":"Data Assets | Johns Hopkins Center for Drug Safety and Effectiveness. https:\/\/publichealth.jhu.edu\/center-for-drug-safety-and-effectiveness\/data-assets."},{"key":"791_CR20","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.2522\/ptj.20150037","volume":"95","author":"JM Fritz","year":"2015","unstructured":"Fritz JM, Kim J, Thackeray A, et al. Use of physical therapy for low back pain by Medicaid enrollees. Phys Ther. 2015;95:1668\u201379.","journal-title":"Phys Ther"},{"key":"791_CR21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.semarthrit.2017.03.010","volume":"47","author":"GS Calip","year":"2017","unstructured":"Calip GS, Adimadhyam S, Xing S, et al. Medication adherence and persistence over time with self-administered TNF-alpha inhibitors among young adult, middle-aged, and older patients with rheumatologic conditions. Semin Arthritis Rheum. 2017;47:157\u201364.","journal-title":"Semin Arthritis Rheum"},{"key":"791_CR22","doi-asserted-by":"publisher","first-page":"4061","DOI":"10.1007\/s10067-021-05713-8","volume":"40","author":"JF Merola","year":"2021","unstructured":"Merola JF, Dennis N, Chakravarty SD, et al. Healthcare utilization and costs among patients with psoriasis and psoriatic arthritis in the USA\u2014a retrospective study of claims data from 2009 to 2020. Clin Rheumatol. 2021;40:4061\u201370.","journal-title":"Clin Rheumatol"},{"key":"791_CR23","first-page":"27","volume":"27","author":"E Yi","year":"2021","unstructured":"Yi E, Dai D, Piao OW, et al. Health care utilization and cost associated with switching biologics within the first year of biologic treatment initiation among patients with ankylosing spondylitis. J Manag Care Spec Pharm. 2021;27:27\u201336.","journal-title":"J Manag Care Spec Pharm"},{"key":"791_CR24","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/acr2.11316","volume":"3","author":"JR Curtis","year":"2021","unstructured":"Curtis JR, Winthrop K, Bohn RL, et al. The annual diagnostic prevalence of ankylosing spondylitis and axial spondyloarthritis in the United States using Medicare and MarketScan databases. ACR Open Rheumatol. 2021;3:743\u201352.","journal-title":"ACR Open Rheumatol"},{"key":"791_CR25","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1007\/s40744-024-00710-0","volume":"11","author":"A Danve","year":"2024","unstructured":"Danve A, Vadhariya A, Lisse J, et al. Ixekizumab treatment patterns and health care resource utilization among patients with axial spondyloarthritis: a retrospective United States claims database study. Rheumatol Ther. 2024;11:1333\u201345.","journal-title":"Rheumatol Ther"},{"key":"791_CR26","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/art.43082","volume":"77","author":"D Driscoll","year":"2025","unstructured":"Driscoll D, George N, Peloquin C, et al. Association of therapies for axial spondyloarthritis on the risk of hip and spine fractures. Arthritis Rheumatol. 2025;77:677\u201385.","journal-title":"Arthritis Rheumatol"},{"key":"791_CR27","doi-asserted-by":"publisher","first-page":"4358","DOI":"10.1007\/s12325-023-02558-2","volume":"40","author":"S Hopson","year":"2023","unstructured":"Hopson S, Gibbs LR, Syed S, et al. Treatment patterns and healthcare resource utilization among newly diagnosed psoriasis, psoriatic arthritis, axial spondyloarthritis, and hidradenitis suppurativa patients with past diagnosis of an inflammatory condition: a retrospective cohort analysis of claims data in the United States. Adv Ther. 2023;40:4358\u201376.","journal-title":"Adv Ther"},{"key":"791_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003504","volume":"10","author":"M Garrido-Cumbrera","year":"2024","unstructured":"Garrido-Cumbrera M, Poddubnyy D, Sommerfleck F, et al. International map of axial spondyloarthritis (IMAS): results from the perspective of 5557 patients from 27 countries around the globe. RMD Open. 2024;10:e003504.","journal-title":"RMD Open"},{"key":"791_CR29","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s40744-024-00672-3","volume":"11","author":"M Garrido-Cumbrera","year":"2024","unstructured":"Garrido-Cumbrera M, Poddubnyy D, Sommerfleck F, et al. Regional differences in diagnosis journey and healthcare utilization: results from the International Map of Axial Spondyloarthritis (IMAS). Rheumatol Ther. 2024;11:927\u201345.","journal-title":"Rheumatol Ther"},{"key":"791_CR30","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1002\/acr.24025","volume":"71","author":"MM Ward","year":"2019","unstructured":"Ward MM, Deodhar A, Gensler LS, et al. 2019 update of the American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and Treatment Network recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Care Res (Hoboken). 2019;71:1285\u201399.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"791_CR31","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2147\/CEOR.S144209","volume":"10","author":"FS Mennini","year":"2018","unstructured":"Mennini FS, Viti R, Marcellusi A, et al. Economic evaluation of spondyloarthritis: economic impact of diagnostic delay in Italy. Clinicoecon Outcomes Res. 2018;10:45\u201351.","journal-title":"Clinicoecon Outcomes Res"},{"key":"791_CR32","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s40744-020-00194-8","volume":"7","author":"E Yi","year":"2020","unstructured":"Yi E, Ahuja A, Rajput T, et al. Clinical, economic, and humanistic burden associated with delayed diagnosis of axial spondyloarthritis: a systematic review. Rheumatol Ther. 2020;7:65\u201387.","journal-title":"Rheumatol Ther"},{"key":"791_CR33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00296-002-0237-4","volume":"23","author":"E Feldtkeller","year":"2003","unstructured":"Feldtkeller E, Khan MA, van der Heijde D, et al. Age at disease onset and diagnosis delay in HLA-B27-negative vs -positive patients with ankylosing spondylitis. Rheumatol Int. 2003;23:61\u20136.","journal-title":"Rheumatol Int"},{"key":"791_CR34","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3899\/jrheum.160825","volume":"44","author":"V Jovan\u00ed","year":"2017","unstructured":"Jovan\u00ed V, Blasco-Blasco M, Ruiz-Cantero MT, et al. Understanding how the diagnostic delay of spondyloarthritis differs between women and men: a systematic review and metaanalysis. J Rheumatol. 2017;44:174\u201383.","journal-title":"J Rheumatol"},{"key":"791_CR35","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1093\/rheumatology\/kez090","volume":"58","author":"I Redeker","year":"2019","unstructured":"Redeker I, Callhoff J, Hoffmann F, et al. Determinants of diagnostic delay in axial spondyloarthritis: an analysis based on linked claims and patient-reported survey data. Rheumatology (Oxford). 2019;58:1634\u20138.","journal-title":"Rheumatology (Oxford)"},{"key":"791_CR36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11926-018-0744-2","volume":"20","author":"T Rusman","year":"2018","unstructured":"Rusman T, van Vollenhoven RF, van der Horst-Bruinsma IE. Gender differences in axial spondyloarthritis: women are not so lucky. Curr Rheumatol Rep. 2018;20:35.","journal-title":"Curr Rheumatol Rep"},{"key":"791_CR37","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.15433","volume":"27","author":"V Navarro-Comp\u00e1n","year":"2024","unstructured":"Navarro-Comp\u00e1n V, Garrido-Cumbrera M, Poddubnyy D, et al. Females with axial spondyloarthritis have longer diagnostic delay and higher burden of the disease. Results from the International Map of Axial Spondyloarthritis (IMAS). Int J Rheum Dis. 2024;27:e15433.","journal-title":"Int J Rheum Dis"},{"key":"791_CR38","doi-asserted-by":"publisher","first-page":"rkae102","DOI":"10.1093\/rap\/rkae102","volume":"8","author":"A Chan","year":"2024","unstructured":"Chan A, Rigler K, Ahmad N, et al. Progressive improvement in time to diagnosis in axial spondyloarthritis through an integrated referral and education system. Rheumatol Adv Pract. 2024;8:rkae102.","journal-title":"Rheumatol Adv Pract"},{"key":"791_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2023.101871","volume":"37","author":"FA van Gaalen","year":"2023","unstructured":"van Gaalen FA, Rudwaleit M. Challenges in the diagnosis of axial spondyloarthritis. Best Pract Res Clin Rheumatol. 2023;37:101871.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"791_CR40","first-page":"344","volume":"52","author":"R Ferrandiz-Espadin","year":"2024","unstructured":"Ferrandiz-Espadin R, Rabasa G, Gasman S, et al. Disparities in time to diagnosis of radiographic axial spondyloarthritis. J Rheumatol. 2025;52:344\u201351.","journal-title":"J Rheumatol"},{"key":"791_CR41","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1093\/pm\/pny074","volume":"20","author":"DP Ly","year":"2019","unstructured":"Ly DP. Racial and ethnic disparities in the evaluation and management of pain in the outpatient setting, 2006\u20132015. Pain Med. 2019;20:223\u201332.","journal-title":"Pain Med"},{"key":"791_CR42","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1097\/BRS.0000000000002499","volume":"43","author":"CJ Milani","year":"2018","unstructured":"Milani CJ, Rundell SD, Jarvik JG, et al. Associations of race and ethnicity with patient-reported outcomes and health care utilization among older adults initiating a new episode of care for back pain. Spine (Phila PA 1976). 2018;43:1007\u201317.","journal-title":"Spine (Phila PA 1976)"}],"container-title":["Rheumatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-025-00791-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40744-025-00791-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-025-00791-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T12:03:14Z","timestamp":1758369794000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40744-025-00791-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["791"],"URL":"https:\/\/doi.org\/10.1007\/s40744-025-00791-5","relation":{},"ISSN":["2198-6576","2198-6584"],"issn-type":[{"type":"print","value":"2198-6576"},{"type":"electronic","value":"2198-6584"}],"subject":[],"published":{"date-parts":[[2025,8,29]]},"assertion":[{"value":"15 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Maureen Dubreuil: Received educational grant from Pfizer paid to institution; received consulting fees from Amgen and UCB; Marina Magrey: Received consultancy fees from AbbVie, BMS, Eli Lilly, Novartis, Pfizer, and UCB; received research grants from AbbVie, BMS, and UCB; Kathrin Haeffs, Evgueni Ivanov, Julie Gandrup Horan: Employees and shareholders of UCB.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies, performed by any of the authors, with human participants or animals. As the study analyzed a retrospective anonymized dataset, no ethical review and no informed consent of patients was needed. However, the study protocol was reviewed by a scientific steering committee and the data owner. The work on the dataset conformed to all social security data protection requirements.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}